Midatech Pharma Plc

Midatech Pharma is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The Company combines approved and development medications with its proprietary and innovative drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.

Midatech’s ordinary shares are traded on the Alternative Investment Market (AIM) of the London Stock Exchange under the ticker symbol MTPH (CUSIP number GB00BKT14T00). Midatech’s American Depositary Shares trade on the NASDAQ Capital Market in the United States under the symbol MTP (CUSIP No. 59564R302).

Midatech’s Q-Sphera technology focusses on long acting injectables using proprietary 3D printing technology that encapsulates medicines into bioresorbable polymer microspheres with precision characteristics.

In partnership, we use our rapid R&D innovation to enable drugs to reach areas of the body where they are needed and to exert their actions in a tuneable, effective and precise manner.